Circulating tumour mutation detection in triple-negative breast cancer as an adjunct to tissue response assessment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Circulating tumour mutation detection in triple-negative breast cancer as an adjunct to tissue response assessment ; volume:10 ; number:1 ; day:5 ; month:1 ; year:2024 ; pages:1-9 ; date:12.2024
npj Breast cancer ; 10, Heft 1 (5.1.2024), 1-9, 12.2024
- Urheber
-
Zaikova, Elena
Cheng, Brian Y. C.
Cerda, Viviana
Kong, Esther
Lai, Daniel
Lum, Amy
Bates, Cherie
Brok, Wendie den
Kono, Takako
Bourque, Sylvie
Chan, Angela
Feng, Xioalan
Fenton, David
Gurjal, Anagha
Levasseur, Nathalie
Lohrisch, Caroline
Roberts, Sarah
Shenkier, Tamara
Simmons, Christine
Taylor, Sara
Villa, Diego
Miller, Ruth
Aguirre-Hernandez, Rosalia
Aparicio, Samuel
Gelmon, Karen
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41523-023-00607-1
- URN
-
urn:nbn:de:101:1-2024031822042400620029
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zaikova, Elena
- Cheng, Brian Y. C.
- Cerda, Viviana
- Kong, Esther
- Lai, Daniel
- Lum, Amy
- Bates, Cherie
- Brok, Wendie den
- Kono, Takako
- Bourque, Sylvie
- Chan, Angela
- Feng, Xioalan
- Fenton, David
- Gurjal, Anagha
- Levasseur, Nathalie
- Lohrisch, Caroline
- Roberts, Sarah
- Shenkier, Tamara
- Simmons, Christine
- Taylor, Sara
- Villa, Diego
- Miller, Ruth
- Aguirre-Hernandez, Rosalia
- Aparicio, Samuel
- Gelmon, Karen
- SpringerLink (Online service)
Ähnliche Objekte (12)
Metastatic Triple-Negative Breast Cancer
AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients
The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence
Biomarkers in cancer/Circulating tumour markers
Tumour immune characterisation of primary triple-negative breast cancer using automated image quantification of immunohistochemistry-stained immune cells
MicroRNA signatures in triple-negative breast cancer
Immune-related biomarkers in triple-negative breast cancer
New Vaccine Therapy for Triple-Negative Breast Cancer
Advances in immunotherapy for triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients
The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence
Biomarkers in cancer/Circulating tumour markers
Tumour immune characterisation of primary triple-negative breast cancer using automated image quantification of immunohistochemistry-stained immune cells
MicroRNA signatures in triple-negative breast cancer
Immune-related biomarkers in triple-negative breast cancer
New Vaccine Therapy for Triple-Negative Breast Cancer
Advances in immunotherapy for triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients
The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence
Biomarkers in cancer/Circulating tumour markers
Tumour immune characterisation of primary triple-negative breast cancer using automated image quantification of immunohistochemistry-stained immune cells
MicroRNA signatures in triple-negative breast cancer
Immune-related biomarkers in triple-negative breast cancer
New Vaccine Therapy for Triple-Negative Breast Cancer